| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Canada | 3 | |
| #3 | China | 3 | |
| #4 | United States | 2 | |
| #5 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Special acyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Organic chemistry methods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Berkman Clifford | 8 |
| #2 | Stekhova Svetlana A | 5 |
| #3 | Berkman Cliff | 4 |
| #4 | Langton-Webster Bea | 3 |
| #5 | Wang Xiaobing | 2 |
| #6 | Graham Keith | 2 |
| #7 | Siebeneicher Holger | 2 |
| #8 | Berkman Clifford E | 1 |
| #9 | X Wang | 1 |
| #10 | Lesche Ralf | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA2903131A1 | 18f-labeled psma-targeted pet imaging agents | |
| WO2013173630A1 | Formulation of radiopharmaceuticals containing multiple acidic groups | |
| WO2013173583A1 | Psma inhibitors | |
| WO2007106869A1 | Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use |